Additional file 2: Table S2. of The gene–treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry

Clinical characteristics according to PON1 genotype. Data are expressed as mean ± SD, median (interquartile), and n (percentage). CVD: cardiovascular disease, OHA: oral hypoglycemic agents, α-GI: alpha-glucosidase inhibitor, DPP4-I: inhibitors of type 4 dipeptidyl peptidase* log-transformed for the statistical analysis. (DOCX 14 kb)